List of Tables
Table 1. Global Peptide Cancer Vaccine Sales (US$ Million) Growth Rate by Pipeline (2017 & 2021 & 2028)
Table 2. Global Peptide Cancer Vaccine Sales ((US$ Million)) Comparison by Application (2017 & 2021 & 2028)
Table 3. Global Peptide Cancer Vaccine Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028
Table 4. Global Peptide Cancer Vaccine Sales (K Doses) by Region (2017-2022)
Table 5. Global Peptide Cancer Vaccine Sales Market Share by Region (2017-2022)
Table 6. Global Peptide Cancer Vaccine Revenue (US$ Million) Market Share by Region (2017-2022))
Table 7. Global Peptide Cancer Vaccine Revenue Share by Region (2017-2022)
Table 8. Global Peptide Cancer Vaccine Sales (K Doses) Forecast by Region (2023-2028)
Table 9. Global Peptide Cancer Vaccine Sales Market Share Forecast by Region (2023-2028)
Table 10. Global Peptide Cancer Vaccine Revenue (US$ Million) Forecast by Region (2023-2028)
Table 11. Global Peptide Cancer Vaccine Revenue Share Forecast by Region (2023-2028)
Table 12. Global Peptide Cancer Vaccine Sales by Company (K Doses) & (2017-2022)
Table 13. Global Peptide Cancer Vaccine Sales Share by Company (2017-2022)
Table 14. Global Peptide Cancer Vaccine Revenue by Company (US$ Million) & (2017-2022)
Table 15. Global Peptide Cancer Vaccine Revenue Share by Company (2017-2022)
Table 16. Global Peptide Cancer Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Peptide Cancer Vaccine as of 2021)
Table 17. Global Market Peptide Cancer Vaccine Average Price by Company (USD/Dose) & (2017-2022)
Table 18. Manufacturers Peptide Cancer Vaccine Manufacturing Sites and Area Served
Table 19. Manufacturers Peptide Cancer Vaccine Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Peptide Cancer Vaccine Sales by Pipeline (2017-2022) & (K Doses)
Table 22. Global Peptide Cancer Vaccine Sales Share by Pipeline (2017-2022)
Table 23. Global Peptide Cancer Vaccine Revenue Market Share by Pipeline (2017-2022) & (US$ Million)
Table 24. Global Peptide Cancer Vaccine Price by Pipeline (2017-2022) & (USD/Dose)
Table 25. Global Peptide Cancer Vaccine Sales Share by Pipeline (2023-2028)
Table 26. Global Peptide Cancer Vaccine Revenue Market Share by Pipeline (2023-2028) & (US$ Million)
Table 27. Global Peptide Cancer Vaccine Revenue Share by Pipeline (2023-2028)
Table 28. Global Peptide Cancer Vaccine Price by Pipeline (2023-2028) & (USD/Dose)
Table 29. Global Peptide Cancer Vaccine Sales by Application (2017-2022) & (K Doses)
Table 30. Global Peptide Cancer Vaccine Sales Share by Application (2017-2022)
Table 31. Global Peptide Cancer Vaccine Revenue Market Share by Application (2017-2022) & (US$ Million)
Table 32. Global Peptide Cancer Vaccine Price by Application (2017-2022) & (USD/Dose)
Table 33. Global Peptide Cancer Vaccine Sales by Application (2023-2028) & (K Doses)
Table 34. Global Peptide Cancer Vaccine Sales Share by Application (2023-2028)
Table 35. Global Peptide Cancer Vaccine Revenue Market Share by Application (2023-2028) & (US$ Million)
Table 36. Global Peptide Cancer Vaccine Revenue Share by Application (2023-2028)
Table 37. Global Peptide Cancer Vaccine Price by Application (2023-2028) & (USD/Dose)
Table 38. United States Peptide Cancer Vaccine Sales by Company (2017-2022) & (K Doses)
Table 39. United States Peptide Cancer Vaccine Sales Market Share by Company (2017-2022)
Table 40. United States Peptide Cancer Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 41. United States Peptide Cancer Vaccine Revenue Market Share by Company (2017-2022)
Table 42. United States Peptide Cancer Vaccine Sales by Pipeline (2017-2022) & (K Doses)
Table 43. United States Peptide Cancer Vaccine Sales Market Share by Pipeline (2017-2022)
Table 44. United States Peptide Cancer Vaccine Sales by Pipeline (2023-2028) & (K Doses)
Table 45. United States Peptide Cancer Vaccine Sales Market Share by Pipeline (2023-2028)
Table 46. United States Peptide Cancer Vaccine Sales by Application (2017-2022) & (K Doses)
Table 47. United States Peptide Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 48. United States Peptide Cancer Vaccine Sales by Application (2023-2028) & (K Doses)
Table 49. United States Peptide Cancer Vaccine Sales Market Share by Application (2023-2028)
Table 50. Europe Peptide Cancer Vaccine Sales by Company (2017-2022) & (K Doses)
Table 51. Europe Peptide Cancer Vaccine Sales Market Share by Company (2017-2022)
Table 52. Europe Peptide Cancer Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 53. Europe Peptide Cancer Vaccine Revenue Market Share by Company (2017-2022)
Table 54. Europe Peptide Cancer Vaccine Sales by Pipeline (2017-2022) & (K Doses)
Table 55. Europe Peptide Cancer Vaccine Sales Market Share by Pipeline (2017-2022)
Table 56. Europe Peptide Cancer Vaccine Sales by Pipeline (2023-2028) & (K Doses)
Table 57. Europe Peptide Cancer Vaccine Sales Market Share by Pipeline (2023-2028)
Table 58. Europe Peptide Cancer Vaccine Sales by Application (2017-2022) & (K Doses)
Table 59. Europe Peptide Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 60. Europe Peptide Cancer Vaccine Sales by Application (2023-2028) & (K Doses)
Table 61. Europe Peptide Cancer Vaccine Sales Market Share by Application (2023-2028)
Table 62. China Peptide Cancer Vaccine Sales by Company (2017-2022) & (K Doses)
Table 63. China Peptide Cancer Vaccine Sales Market Share by Company (2017-2022)
Table 64. China Peptide Cancer Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 65. China Peptide Cancer Vaccine Revenue Market Share by Company (2017-2022)
Table 66. China Peptide Cancer Vaccine Sales by Pipeline (2017-2022) & (K Doses)
Table 67. China Peptide Cancer Vaccine Sales Market Share by Pipeline (2017-2022)
Table 68. China Peptide Cancer Vaccine Sales by Pipeline (2023-2028) & (K Doses)
Table 69. China Peptide Cancer Vaccine Sales Market Share by Pipeline (2023-2028)
Table 70. China Peptide Cancer Vaccine Sales by Application (2017-2022) & (K Doses)
Table 71. China Peptide Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 72. China Peptide Cancer Vaccine Sales by Application (2023-2028) & (K Doses)
Table 73. China Peptide Cancer Vaccine Sales Market Share by Application (2023-2028)
Table 74. Japan Peptide Cancer Vaccine Sales by Company (2017-2022) & (K Doses)
Table 75. Japan Peptide Cancer Vaccine Sales Market Share by Company (2017-2022)
Table 76. Japan Peptide Cancer Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 77. Japan Peptide Cancer Vaccine Revenue Market Share by Company (2017-2022)
Table 78. Japan Peptide Cancer Vaccine Sales by Pipeline (2017-2022) & (K Doses)
Table 79. Japan Peptide Cancer Vaccine Sales Market Share by Pipeline (2017-2022)
Table 80. Japan Peptide Cancer Vaccine Sales by Pipeline (2023-2028) & (K Doses)
Table 81. Japan Peptide Cancer Vaccine Sales Market Share by Pipeline (2023-2028)
Table 82. Japan Peptide Cancer Vaccine Sales by Application (2017-2022) & (K Doses)
Table 83. Japan Peptide Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 84. Japan Peptide Cancer Vaccine Sales by Application (2023-2028) & (K Doses)
Table 85. Japan Peptide Cancer Vaccine Sales Market Share by Application (2023-2028)
Table 86. Southeast Asia Peptide Cancer Vaccine Sales by Company (2017-2022) & (K Doses)
Table 87. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Company (2017-2022)
Table 88. Southeast Asia Peptide Cancer Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 89. Southeast Asia Peptide Cancer Vaccine Revenue Market Share by Company (2017-2022)
Table 90. Southeast Asia Peptide Cancer Vaccine Sales by Pipeline (2017-2022) & (K Doses)
Table 91. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Pipeline (2017-2022)
Table 92. Southeast Asia Peptide Cancer Vaccine Sales by Pipeline (2023-2028) & (K Doses)
Table 93. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Pipeline (2023-2028)
Table 94. Southeast Asia Peptide Cancer Vaccine Sales by Application (2017-2022) & (K Doses)
Table 95. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 96. Southeast Asia Peptide Cancer Vaccine Sales by Application (2023-2028) & (K Doses)
Table 97. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Application (2023-2028)
Table 98. India Peptide Cancer Vaccine Sales by Company (2017-2022) & (K Doses)
Table 99. India Peptide Cancer Vaccine Sales Market Share by Company (2017-2022)
Table 100. India Peptide Cancer Vaccine Revenue by Company (2017-2022) & (US$ Million)
Table 101. India Peptide Cancer Vaccine Revenue Market Share by Company (2017-2022)
Table 102. India Peptide Cancer Vaccine Sales by Pipeline (2017-2022) & (K Doses)
Table 103. India Peptide Cancer Vaccine Sales Market Share by Pipeline (2017-2022)
Table 104. India Peptide Cancer Vaccine Sales by Pipeline (2023-2028) & (K Doses)
Table 105. India Peptide Cancer Vaccine Sales Market Share by Pipeline (2023-2028)
Table 106. India Peptide Cancer Vaccine Sales by Application (2017-2022) & (K Doses)
Table 107. India Peptide Cancer Vaccine Sales Market Share by Application (2017-2022)
Table 108. India Peptide Cancer Vaccine Sales by Application (2023-2028) & (K Doses)
Table 109. India Peptide Cancer Vaccine Sales Market Share by Application (2023-2028)
Table 110. Boston Biomedical Corporation Information
Table 111. Boston Biomedical Description and Business Overview
Table 112. Boston Biomedical Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 113. Boston Biomedical Peptide Cancer Vaccine Product
Table 114. Boston Biomedical Recent Development
Table 115. Ultimovacs Corporation Information
Table 116. Ultimovacs Description and Business Overview
Table 117. Ultimovacs Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 118. Ultimovacs Peptide Cancer Vaccine Product
Table 119. Ultimovacs Recent Development
Table 120. BrightPath Biotherapeutics Corporation Information
Table 121. BrightPath Biotherapeutics Description and Business Overview
Table 122. BrightPath Biotherapeutics Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 123. BrightPath Biotherapeutics Peptide Cancer Vaccine Product
Table 124. BrightPath Biotherapeutics Recent Development
Table 125. TapImmune Corporation Information
Table 126. TapImmune Description and Business Overview
Table 127. TapImmune Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 128. TapImmune Peptide Cancer Vaccine Product
Table 129. TapImmune Recent Development
Table 130. Immatics Corporation Information
Table 131. Immatics Description and Business Overview
Table 132. Immatics Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 133. Immatics Peptide Cancer Vaccine Product
Table 134. Immatics Recent Development
Table 135. Sellas Corporation Information
Table 136. Sellas Description and Business Overview
Table 137. Sellas Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 138. Sellas Peptide Cancer Vaccine Product
Table 139. Sellas Recent Development
Table 140. Imugene Corporation Information
Table 141. Imugene Description and Business Overview
Table 142. Imugene Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 143. Imugene Peptide Cancer Vaccine Product
Table 144. Imugene Recent Development
Table 145. VAXON Biotech Corporation Information
Table 146. VAXON Biotech Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 147. VAXON Biotech Description and Business Overview
Table 148. VAXON Biotech Peptide Cancer Vaccine Product
Table 149. VAXON Biotech Recent Development
Table 150. Generex Biotechnology Corporation Information
Table 151. Generex Biotechnology Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 152. Generex Biotechnology Description and Business Overview
Table 153. Generex Biotechnology Peptide Cancer Vaccine Product
Table 154. Generex Biotechnology Recent Development
Table 155. ISA Pharmaceuticals Corporation Information
Table 156. ISA Pharmaceuticals Description and Business Overview
Table 157. ISA Pharmaceuticals Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 158. ISA Pharmaceuticals Peptide Cancer Vaccine Product
Table 159. ISA Pharmaceuticals Recent Development
Table 160. OncoTherapy Science Corporation Information
Table 161. OncoTherapy Science Description and Business Overview
Table 162. OncoTherapy Science Peptide Cancer Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 163. OncoTherapy Science Peptide Cancer Vaccine Product
Table 164. OncoTherapy Science Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Peptide Cancer Vaccine Distributors List
Table 168. Peptide Cancer Vaccine Customers List
Table 169. Peptide Cancer Vaccine Market Trends
Table 170. Peptide Cancer Vaccine Market Drivers
Table 171. Peptide Cancer Vaccine Market Challenges
Table 172. Peptide Cancer Vaccine Market Restraints
Table 173. Research Programs/Design for This Report
Table 174. Key Data Information from Secondary Sources
Table 175. Key Data Information from Primary Sources
List of Figures
Figure 1. Peptide Cancer Vaccine Product Picture
Figure 2. Global Peptide Cancer Vaccine Sales Market Share by Pipeline in 2021 & 2028
Figure 3. ITK-1 Product Picture
Figure 4. GRN-1201 Product Picture
Figure 5. TPIV200 Product Picture
Figure 6. TPIV110 Product Picture
Figure 7. UV1 Product Picture
Figure 8. Galinpepimut-S Product Picture
Figure 9. TARP 27-35 Product Picture
Figure 10. HER-Vaxx Product Picture
Figure 11. Vx-001 Product Picture
Figure 12. Others Product Picture
Figure 13. Global Peptide Cancer Vaccine Sales Market Share by Application in 2021 & 2028
Figure 14. Breast Cancer Examples
Figure 15. Lung Cancer Examples
Figure 16. Melanoma Examples
Figure 17. Prostate Cancer Examples
Figure 18. Others Examples
Figure 19. Global Peptide Cancer Vaccine Sales, (US$ Million), 2017 VS 2021 VS 2028
Figure 20. Global Peptide Cancer Vaccine Sales Growth Rate (2017-2028) & (US$ Million)
Figure 21. Global Peptide Cancer Vaccine Sales (K Doses) Growth Rate (2017-2028)
Figure 22. Global Peptide Cancer Vaccine Price Trends Growth Rate (2017-2028) & (USD/Dose)
Figure 23. Global Peptide Cancer Vaccine Revenue Market Share by Region: 2021 VS 2028
Figure 24. United States Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2017-2028)
Figure 25. United States Peptide Cancer Vaccine Sales (K Doses) Growth Rate (2017-2028)
Figure 26. Europe Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2017-2028)
Figure 27. Europe Peptide Cancer Vaccine Sales (US$ Million) Growth Rate (2017-2028)
Figure 28. China Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2017-2028)
Figure 29. China Peptide Cancer Vaccine Sales (US$ Million) and Growth Rate (2017-2028)
Figure 30. Japan Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2017-2028)
Figure 31. Japan Peptide Cancer Vaccine Sales (US$ Million) Growth Rate (2017-2028)
Figure 32. Southeast Asia Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2017-2028)
Figure 33. Southeast Asia Peptide Cancer Vaccine Sales (US$ Million) Growth Rate (2017-2028)
Figure 34. India Peptide Cancer Vaccine Revenue (US$ Million) Growth Rate (2017-2028)
Figure 35. India Peptide Cancer Vaccine Sales (US$ Million) Growth Rate (2017-2028)
Figure 36. Global 5 Largest Peptide Cancer Vaccine Players Market Share by Revenue in Peptide Cancer Vaccine: 2017 & 2021
Figure 37. Peptide Cancer Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 38. Global Peptide Cancer Vaccine Revenue Share by Pipeline (2017-2022)
Figure 39. Global Peptide Cancer Vaccine Revenue Share by Application (2017-2022)
Figure 40. Global Peptide Cancer Vaccine Revenue Growth Rate by Application in 2017 & 2021
Figure 41. United States Peptide Cancer Vaccine Sales Market Share by Pipeline in 2021
Figure 42. United States Peptide Cancer Vaccine Sales Market Share by Application in 2021
Figure 43. Europe Peptide Cancer Vaccine Sales Market Share by Pipeline in 2021
Figure 44. Europe Peptide Cancer Vaccine Sales Market Share by Application in 2021
Figure 45. China Peptide Cancer Vaccine Sales Market Share by Pipeline in 2021
Figure 46. China Peptide Cancer Vaccine Sales Market Share by Application in 2021
Figure 47. Japan Peptide Cancer Vaccine Sales Market Share by Pipeline in 2021
Figure 48. Japan Peptide Cancer Vaccine Sales Market Share by Application in 2021
Figure 49. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Pipeline in 2021
Figure 50. Southeast Asia Peptide Cancer Vaccine Sales Market Share by Application in 2021
Figure 51. India Peptide Cancer Vaccine Sales Market Share by Pipeline in 2021
Figure 52. India Peptide Cancer Vaccine Sales Market Share by Application in 2021
Figure 53. Key Raw Materials Price Trend
Figure 54. Manufacturing Cost Structure of Peptide Cancer Vaccine
Figure 55. Manufacturing Process Analysis of Peptide Cancer Vaccine
Figure 56. Peptide Cancer Vaccine Industrial Chain Analysis
Figure 57. Channels of Distribution
Figure 58. Distributors Profiles
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
